Melanoma
Showing NaN - NaN of 71
Melanoma, Skin Cancer Trial in Worldwide (BMS-986205, Nivolumab, Placebo)
Metastatic Cancer, Melanoma, Gastric Cancer Trial in United States (VE800, Nivolumab, Vancomycin Oral Capsule)
Active, not recruiting
- Metastatic Cancer
- +4 more
- VE800
- +2 more
-
Scottsdale, Arizona
- +17 more
Jun 22, 2021
Melanoma Trial in Chicago (Minimal Intervention, Intensive Intervention)
Completed
- Melanoma
- Minimal Intervention
- Intensive Intervention
-
Chicago, IllinoisNorthwestern University Feinberg School of Medicine Department o
Mar 23, 2021
Melanoma Trial in Chicago (Skin Self- examination structured training)
Completed
- Melanoma
- Skin Self- examination structured training
-
Chicago, IllinoisJune K Robinson
Mar 9, 2021
Melanoma Trial in Chicago (4-peptide melanoma vaccine, Ontak)
Terminated
- Melanoma
- 4-peptide melanoma vaccine
- Ontak
-
Chicago, IllinoisUniversity of Chicago
Jan 6, 2021
Melanoma Trial in Worldwide (Immunotherapeutic GSK2132231A)
Completed
- Melanoma
- Immunotherapeutic GSK2132231A
-
Los Angeles, California
- +62 more
Dec 7, 2020
Melanoma Trial in Worldwide (pembrolizumab + epacadostat, pembrolizumab + )
Completed
- Melanoma
- pembrolizumab + epacadostat
- pembrolizumab + placebo
-
Birmingham, Alabama
- +128 more
Aug 14, 2020
Melanoma Trial in United States (glembatumumab vedotin, glembatumumab vedotin and varlilumab, glembatumumab vedotin and PD-1
Terminated
- Melanoma
- glembatumumab vedotin
- +3 more
-
Los Angeles, California
- +13 more
Sep 5, 2019
Breast Cancer, Brain Cancer, Gastrointestinal Cancers Trial in Chicago (IGF-Methotrexate conjugate)
Completed
- Breast Cancer
- +7 more
- IGF-Methotrexate conjugate
-
Chicago, IllinoisUniversity of Illinois at Chicago
Aug 20, 2019
Melanoma Trial in Worldwide (Durvalumab, Dabrafenib, Trametinib)
Completed
- Melanoma
- Durvalumab
- +2 more
-
Scottsdale, Arizona
- +10 more
May 15, 2019
Melanoma Trial in Chicago (Eviderma Smart Phone Teledermatology Application (Eviderma))
Withdrawn
- Melanoma
- Eviderma Smart Phone Teledermatology Application (Eviderma)
-
Chicago, IllinoisNorthwestern University Feinberg School of Medicine Department o
Nov 14, 2018
Mucosal Lentiginous Melanoma, Acral Melanoma, Melanoma Trial in United States (Nilotinib)
Completed
- Mucosal Lentiginous Melanoma
- +2 more
-
Santa Monica, California
- +7 more
Oct 16, 2018
Tumor, Cancer, Melanoma Trial in Chicago (Hypofractionated RT)
Completed
- Tumor
- +4 more
- Hypofractionated RT
-
Chicago, IllinoisUniversity of Chicago
Sep 10, 2018
Melanoma Trial in Worldwide (Tasisulam-sodium, Paclitaxel)
Terminated
- Melanoma
-
Birmingham, Alabama
- +121 more
Jun 18, 2018
Melanoma, Nevi, Skin Moles Trial in Chicago (Educational training program)
Completed
- Melanoma
- +2 more
- Educational training program
-
Chicago, Illinois
- +1 more
Jun 5, 2018
Melanoma Trial in United States (Minimally invasive inguinal lymph node dissection)
Completed
- Melanoma
- Minimally invasive inguinal lymph node dissection
-
Scottsdale, Arizona
- +10 more
Mar 21, 2018
Prostatic Tumors, Breast Tumors, Colorectal Tumors Trial in United States (Interactive Voice Response (IVR) Reminders)
Completed
- Prostatic Neoplasms
- +4 more
- Interactive Voice Response (IVR) Reminders
-
New Haven, Connecticut
- +7 more
Jun 6, 2017